IFNA1 and pregnancy disorder: Here, we identified 2BAct‐mediated ISR inhibition as a potential therapeutic strategy for treating these pregnancy disorders by targeting a specific IFN downstream effector while maintaining other antiviral responses, although achieving clinical transformation requires more comprehensive studies.